[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tela Bio Inc (TELA)

Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tela Bio Inc 1 GREAT VALLEY PARKWAY SUITE 24 MALVERN PA 19355 USA

www.telabio.com Employees: 150 P: 484-320-2930

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered in Malvern, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 38,476
Enterprise Value, $K 43,276
Shares Outstanding, K 44,740
Float, K 42,637
% Float 95.30%
Short Interest, K 757
Short Float 1.69%
Days to Cover 4.56
Short Volume Ratio 0.43
% of Insider Shareholders 4.70%
% of Institutional Shareholders 94.35%

Financials:

Annual Sales, $ 80,280 K
Annual Net Income, $ -38,830 K
Last Quarter Sales, $ 20,870 K
Last Quarter Net Income, $ -9,040 K
EBIT, $ -33,380 K
EBITDA, $ -32,370 K

Growth:

1-Year Return -9.81%
3-Year Return -91.17%
5-Year Return -93.33%
5-Year Revenue Growth 340.86%
5-Year Earnings Growth 63.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 03/24/26
Next Earnings Date 05/12/26 [AMC]
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr 15.79%
EPS Growth vs. Prev Year 30.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TELA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -433.58%
Return-on-Assets % -53.00%
Profit Margin % -48.37%
Debt/Equity 8.82
Price/Sales 0.43
Price/Cash Flow N/A
Price/Book 4.98
Book Value/Share 0.16
Interest Coverage -6.35
60-Month Beta 0.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.